Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-606-6856
Dr. Harris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Harris specializes in caring for people with gastrointestinal malignancies including hepatobiliary and pancreatic cancer.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2007 - 2009- University of WashingtonResidency, Internal Medicine, 2001 - 2004
Columbia University Vagelos College of Physicians and SurgeonsClass of 2001
Certifications & Licensure
WA State Medical License 2001 - 2025
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy Start of enrollment: 2011 Jul 01
- Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer Start of enrollment: 2012 Jan 01
- Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer Start of enrollment: 2012 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsOptimal patient selection for yttrium-90 glass plus chemotherapy in the treatment of colorectal liver metastases: additional quality of life, efficacy, and safety anal...Riad Salem, Etienne Garin, Eveline Boucher, Kirk Fowers, Marnix Lam
The Oncologist. 2024-08-05 - 7 citationsA Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma.Shawn Yu, Menggang Yu, Barry Keane, David M Mauro, Paul R Helft
The Oncologist. 2024-03-04 - Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma-a real-world, multicenter study.Michael Li, Lindsay M Hannan, Lipika Goyal, Andrea G Bocobo, Anna L Parks
Therapeutic Advances in Medical Oncology. 2024-01-01
Press Mentions
A Daughter Gives Her Mom the Gift of ‘Renewed Time’ by Donating Part of Her Liver in a Rare Transplant at UWFebruary 4th, 2021
SCCA’s Immunotherapy Leaders Featured at the American Society of Clinical Oncology (ASCO) Annual MeetingMay 31st, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
